Open Access 2.0

Open Access 2.0 © Grant Faint/Getty Images The nautilus: where - and how - OA will actually work By Joseph J. Esposito Related Articles The nautilus model of scientific publishing OA, OK? The debate over open access to the scientific literature appears to be moving onto a new phase. Many continue to argue one side or the other of a binary choice: Either all research publishing should be open access, or only traditional publishing can maintain

| 13 min read

Register for free to listen to this article
Listen with Speechify
0:00
13:00
Share

By Joseph J. Esposito

The nautilus model of scientific publishing

OA, OK?

The debate over open access to the scientific literature appears to be moving onto a new phase. Many continue to argue one side or the other of a binary choice: Either all research publishing should be open access, or only traditional publishing can maintain peer review and editorial integrity. Others, however, have moved beyond that false dichotomy, instead increasingly seeing various hybrid models emerging and new, often complex, business arrangements.

Partly this is a product of the apparent inability of open-access ventures to produce economically sustainable models. It is unclear whether BioMed Central, a privately held sister company of The Scientist, has broken even, and the Public Library of Science tax return from the fiscal year ending September 30, 2006, the most recent publicly available, indicates that the organization lost $1.4 million on $5 million in revenue. Even ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Joseph J. Esposito

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio